VERTEX PHARMACEUTICALS

(VRTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Most relevant news about VERTEX PHARMACEUTICALS
05/09UBS Adjusts Vertex Pharmaceuticals Price Target to $321 From $322, Maintains Buy Rating
MT
05/06Goldman Sachs Adjusts Price Target for Vertex Pharmaceuticals to $368 From $329, Mainta..
MT
05/06Wells Fargo Adjusts Vertex Pharmaceuticals' Price Target to $305 From $300, Reiterates ..
MT
05/06Baird Downgrades Vertex Pharmaceuticals to Neutral From Outperform, Adjusts Price Targe..
MT
05/06RBC Capital Adjusts Price Target on Vertex Pharmaceuticals to $267 From $274, Keeps Sec..
MT
05/06Piper Sandler Adjusts Price Target on Vertex Pharmaceuticals to $242 From $249, Maintai..
MT
05/05Earnings Flash (VRTX) VERTEX PHARMACEUTICALS INCORPORATED Reports Q1 Revenue $2.1B, vs...
MT
05/05Earnings Flash (VRTX) VERTEX PHARMACEUTICALS INCORPORATED Reports Q1 EPS $3.52, vs. Str..
MT
05/05TRANSCRIPT : Vertex Pharmaceuticals Incorporated, Q1 2022 Earnings Call, May 05, 2022
CI
05/05Vertex Pharmaceuticals Q1 Results Rise; Reaffirms 2022 Product Revenue Guidance
MT
05/05VERTEX : Q1 Earnings Snapshot
AQ
05/05Vertex Reports First Quarter 2022 Financial Results
BU
05/05Vertex Pharmaceuticals Incorporated Reports Earnings Results for the First Quarter Ende..
CI
05/05Vertex Pharmaceuticals Incorporated Reiterates Earning Guidance for 2022
CI
05/05EARNINGS REACTION HISTORY : Vertex Pharmaceuticals, 55.6% Follow-Through Indicator, 2.6% S..
MT
05/03Morgan Stanley Upgrades Vertex Pharmaceuticals to Equalweight From Underweight; Price T..
MT
05/03SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Verte..
PR
05/02Vertex Pharmaceuticals Says FDA Places VX-880 Diabetes Study on Clinical Hold; Shares D..
MT
05/02Vertex Provides Updates on Phase 1/2 Clinical Trial of VX-880 for the Treatment of Type..
BU
05/02Vertex Pharmaceuticals Incorporated Provides Updates on Phase 1/2 Clinical Trial of Vx-..
CI
05/02VERTEX PHARMA : FDA Puts VX-880 Diabetes Study on Hold
DJ
04/27Big Biotech Firms Have Several Catalysts Lined Up, UBS Says
MT
04/27UBS Adjusts Vertex Pharmaceuticals Price Target to $322 From $325, Maintains Buy Rating
MT
04/22Piper Sandler Adjusts Price Target on Vertex Pharmaceuticals to $249 From $245, Maintai..
MT
04/21Vertex to Announce First Quarter 2022 Financial Results on May 5
BU
04/21VRTX - Health Canada Grants Marketing Authorization for TRIKAFTA (elexacaftor/tezacafto..
AQ
04/21Vertex Pharmaceuticals Gets Canada's Approval of Trikafta for Children Aged Six to 11 Y..
MT
04/20Health Canada Grants Marketing Authorization for TRIKAFTA® (elexacaftor/tezacaftor/ivac..
BU
04/20Vertex Pharmaceuticals Incorporated Announces Health Canada Grants Marketing Authorizat..
CI
04/18INSIDER SELL : Vertex Pharmaceuticals
MT
04/13UBS Adjusts Vertex Pharmaceuticals Price Target to $325 From $258, Maintains Buy Rating
MT
04/12INSIDER SELL : Vertex Pharmaceuticals
MT
04/12INSIDER SELL : Vertex Pharmaceuticals
MT
04/12INSIDER SELL : Vertex Pharmaceuticals
MT
04/11INSIDER SELL : Vertex Pharmaceuticals
MT
04/06INSIDER SELL : Vertex Pharmaceuticals
MT
04/06RBC Capital Adjusts Vertex Pharmaceuticals' Price Target to $274 From $269, Maintains S..
MT
04/05INSIDER SELL : Vertex Pharmaceuticals
MT
04/05Wells Fargo Adjusts Price Target on Vertex Pharmaceuticals to $300 From $270, Reiterate..
MT
04/04Oppenheimer Adjusts Vertex Pharmaceuticals' Price Target to $350 From $305, Maintains O..
MT
03/31Vertex Pharmaceuticals Says Treatment for Pain After Certain Surgeries Met Primary Endp..
MT
03/31Vertex Announces Statistically Significant and Clinically Meaningful Results From Two P..
BU
03/31Vertex Pharmaceuticals Incorporated Announces Statistically Significant and Clinically ..
CI
03/31Vertex Pharmaceuticals to Advance VX-548 Pain Drug After Positive Phase 2 Studies
DJ
03/29American Kidney Fund Announces Support from Vertex Pharmaceuticals Inc. to Raise Awaren..
CI
03/28Vertex Announces Reimbursement Agreement in Australia for TRIKAFTA for Patients With Cy..
AQ
03/26Vertex Announces Reimbursement Agreement in Australia for TRIKAFTA® (elexacaftor/tezaca..
BU
03/26Vertex Pharmaceuticals Incorporated Announces Reimbursement Agreement in Australia for ..
CI
03/25Vertex Says Health Canada Gives Marketing Authorization to Expand Use of Kalydeco to Tr..
MT
03/25Health Canada Grants Marketing Authorization for KALYDECO® (ivacaftor) for Patients Wit..
AQ
03/23Piper Sandler Adjusts Vertex Pharmaceuticals' Price Target to $245 From $241, Maintains..
MT
03/22Vertex Pharmaceuticals Advances Kidney Disease Treatment Candidate Into Pivotal Clinica..
MT
03/22Vertex Advances VX-147 Into Pivotal Clinical Development for People With APOL1-Mediated..
BU
03/22Vertex Pharmaceuticals Incorporated Advances VX-147 into Pivotal Clinical Development f..
CI
03/21INSIDER SELL : Vertex Pharmaceuticals
MT
03/21INSIDER SELL : Vertex Pharmaceuticals
MT
03/21INSIDER SELL : Vertex Pharmaceuticals
MT
03/08TRANSCRIPT : Vertex Pharmaceuticals Incorporated Presents at 42nd Annual Cowen Health Care..
CI
03/02Vertex to Present at Cowen's 42nd Annual Health Care Conference on March 8
AQ
03/01Vertex to Present at Cowen's 42nd Annual Health Care Conference on March 8
BU
02/22INSIDER SELL : Vertex Pharmaceuticals
MT
02/16INSIDER SELL : Vertex Pharmaceuticals Inc
MT
02/09Vertex Pharmaceuticals Seeks Acquisitions
CI
02/09Tranche Update on Vertex Pharmaceuticals Incorporated's Equity Buyback Plan announced o..
CI
02/04INSIDER SELL : Vertex Pharmaceuticals
MT
02/04NORTH AMERICAN MORNING BRIEFING : Amazon.com, Snap -2-
DJ
02/03Vertex Pharmaceuticals Downgraded to Sector Perform From Outperform by RBC on Valuation..
MT
02/02INSIDER SELL : Vertex Pharmaceuticals
MT
01/28UBS Adjusts Vertex Pharmaceuticals Price Target to $258 From $256, Maintains Buy Rating
MT
01/27RBC Lifts Price Target on Vertex Pharmaceuticals to $269 From $268, Sees 'Better Pipeli..
MT
01/26VERTEX PHARMACEUTICALS : Q4 2021 Presentation
PU
01/26Vertex Pharmaceutical 4Q Profit Rose on Higher Sales of Trikafta
DJ
01/26TRANSCRIPT : Vertex Pharmaceuticals Incorporated, Q4 2021 Earnings Call, Jan 26, 2022
CI
01/26VERTEX PHARMACEUTICALS : Reports Fourth Quarter 2021 and Full Year Financial Results - For..
PU
01/26Vertex Pharmaceuticals Q4 2021 Adjusted EPS, Revenue Jump; Company Sets 2022 Product Sa..
MT
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on VERTEX PHARMACEUTICALS